Skip to main content
OpenTrials
Completed

NCT Number: NCT00737165

A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)

1. The primary goal for this study is to examine the effectiveness of community-based multimodal intervention program for suicide prevention in relatively high suicide rate region compared to control region. 2. The secondary goal for this study is to explore the effectiveness of community-based multimodal intervention program for suicide prevention in the highly populated regions. In addition, we examine the effectiveness of the prevention program in the all regions combined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Suicide Behavior Behavioral Symptoms Self-Injurious Behavior Suicide Prevention

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Akita region group, Akita, Japan

Loading trial locations.

About this study

Suicide is a major public health problem and the number of suicide victims has exceeded 30,000 a year since 1998 in Japan. Suicide rate is almost 25/100,000, which are remarkably high numbers among advanced countries. To examine the effectiveness of community-based multimodal intervention program for suicide prevention, a trial by J-MISP (Japanese Multimodal Intervention Trials for Suicide Prevention). This research project is one of the strategic research projects funded by The Japanese Ministry of Health, Labor and Welfare.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Areas which meet the following criteria are eligible for this study;
  • An area with firm support from local government and other organizations to conduct this multimodal suicide prevention program
  • An area capable to select intervention and control regions
  • An area capable to follow the data collection procedure described in the protocol
  • An area with comparable baseline data on suicide attempts rate in intervention and control region
  • An area with comparable baseline data on demographics in intervention and control region

Exclusion criteria

  • None

Treatment and study plan

Multimodal suicide prevention program

Behavioral

A community intervention of multimodal suicide prevention program includes following components:

  • Building support networks for suicide prevention and mental health promotion in public health system
  • Primary prevention of suicide and suicide related behaviors
  • Secondary prevention of suicide and suicide related behaviors
  • Tertiary prevention; after care for suicide survivors
  • Suicide prevention targeting for people with substance/alcohol- related disorders , schizophrenia and other mental health disorders
  • Suicide prevention targeting for people with work-related problems

Suicide prevention program as usual

Behavioral

Usual suicide prevention program

Primary outcomes

  1. Incidence of suicide attempts (completed suicides and suicide attempts except mild case )

    Time frame: 3.5years

Secondary outcomes

  1. Incidence of completed suicides

    Time frame: 3.5years

  2. Incidence of suicide attempts

    Time frame: 3.5 years

Sponsors and collaborators

Lead sponsor

Japan Foundation for Neuroscience and Mental Health

Other

Collaborators

  • National Center of Neurology and Psychiatry, Japan

Registry information

Acronym: NOCOMIT-J

Important dates

Study start
2006
Primary completion
2009
Study completion
2011
First posted
Aug 18, 2008
Registry last updated
Oct 31, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.